Clinical Trials Directory

Trials / Completed

CompletedNCT02835651

Saturated Fatty Acids and HDL Metabolism

Effects of C16:0 Versus C18:0 on HDL Metabolism and Other Cardiometabolic Risk Markers: A Dietary Intervention Study in Healthy Normal-weight and Overweight Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
45 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether palmitic acid (C16:0) and stearic acid (C18:0) have different effects on HDL metabolism during the fasted state.

Detailed description

Study design: Double blind, randomized, cross-over study with two different diets: one diet will be high in palmitic acid (C16:0) and the other diet will be high in stearic acid (C18:0). Subjects will receive both diets for 4 weeks with a wash-out period of 4-6 weeks in between. Contrast in the intakes of palmitic acid and stearic acid is 6% of energy. A postprandial test will be carried out at the end of each dietary period. Study population: Accounting for a dropout rate of 20%, 40 healthy men and postmenopausal women, aged between 45 and 70 year, having a BMI (body mass index) between ≥ 18.0 and ≤ 30.0 kg/m2 will be recruited.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPalmitic acidExperimental products are enriched with C16:0
DIETARY_SUPPLEMENTStearic acidExperimental products are enriched with C18:0

Timeline

Start date
2016-04-14
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-07-18
Last updated
2017-08-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02835651. Inclusion in this directory is not an endorsement.